1 option
CADTH Canadian Drug Expert Committee recommendation : indication : adult patients with active psoriatic arthritis (PsA) who have responded inadequately to, or are intolerant to one or more disease-modifying antirheumatic drugs (DMARD). Ixekizumab (Taltz -- Eli Lilly Canada Inc.) / Canadian Agency for Drugs and Technologies in Health.
- Format:
- Book
- Author/Creator:
- Canadian Agency for Drugs and Technologies in Health, author, issuing body.
- Series:
- CADTH common drug review.
- CADTH Common Drug Review
- Language:
- English
- Subjects (All):
- Cost effectiveness.
- Physical Description:
- 1 online resource.
- Edition:
- First edition.
- Place of Publication:
- Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 2018.
- Notes:
- Description based on publisher supplied metadata and other sources.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.